Little Known Facts About phenobarbital sodium water solubility.
Little Known Facts About phenobarbital sodium water solubility.
Blog Article
pentobarbital will lower the extent or effect of alprazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will minimize the level or effect of zolpidem by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Not known.
buprenorphine subdermal implant and pentobarbital both improve sedation. Avoid or Use Alternate Drug. Limit use to individuals for whom alternative treatment selections are inadequate
Contraindicated (one)pentobarbital will decrease the level or effect of naloxegol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Use of naloxegol with solid CYP3A4 inducers is not recommended
pentobarbital will lessen the extent or effect of propafenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unfamiliar.
pentobarbital will minimize the level or effect of maraviroc by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will lessen the level or effect of doravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
Monitor Carefully (one)pentobarbital will minimize the extent or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the extent or effect of nitrendipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unidentified.
pentobarbital and daridorexant each improve sedation. Modify Therapy/Observe Intently. Coadministration improves threat of CNS depression, which can result in additive impairment of psychomotor functionality check here and result in daytime impairment.
pentobarbital will minimize the level or effect of piroxicam by affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Importance Not known.
pentobarbital will reduce the level or effect of colchicine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital and olopatadine intranasal the two increase sedation. Stay clear of or Use Alternate Drug. Coadministration raises hazard of CNS depression, which may lead to additive impairment of psychomotor functionality and cause daytime impairment.
pentobarbital will lower the level or effect of fruquintinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. If coadministration with moderate CYP3A4 inducers is unavoidable, continue to administer fruquintinib at suggested dosage.